On ECHEMI
Home > Drugs > INNER MONGOLIA Huanghe Parmaceutical FACTORY
INNER MONGOLIA Huanghe Parmaceutical FACTORY
  • Founded in:

    1989-03-31
  • Country:

    China China
  • Address:

    No. 41, Shuanghe North Road, Tuoketuo County, Hohhot City, Inner Mongolia Autonomous Region
  • Tax NO.:

    911501221143634247
  • Registered Funds:

    15 million yuan
  • Email:

Related Drugs
Vitamin U Belladonna Aluminum Capsules
This product is a compound preparation. Each tablet contains 140 mg of aluminum hydroxide, 50 mg of vitamin U (iodomethylmethionine), and 10 mg of belladonna extract.
Name Description Content CAS NO. Registered Holders
Aluminum hydroxide

Antacids, which neutralize stomach acid and protect the ulcer surface

More

Antacids, which neutralize stomach acid and protect the ulcer surface

140mg 21645-51-2 14
Vitamin U (iodomethylmethionine)

Promote granulation development and mucosal regeneration

More

Promote granulation development and mucosal regeneration

50mg 0
Atropa Belladonnal

Inhibit glandular secretion and relieve pain caused by smooth spasm

More

Inhibit glandular secretion and relieve pain caused by smooth spasm

10mg 0
Fengtongan Capsules
Stephania tetrandra, tongcao, cinnamon twig, turmeric, gypsum, coix seed, papaya, pittosporum bark, honeysuckle vine, phellodendron, talcum powder, forsythia.
Name Description Content CAS NO. Registered Holders
STEPHANIAE TETRANDRAE RADIX

0
Tetrapanax papyriferus

0
Cmnamomi Mmulus

0
TURMERIC 1G [R]

0
Calcium sulfate dihydrate

10101-41-4 0
COICIS SEMEN

0
Chaenomelis Fructus

0
Bark of Oriental Variegated Coralbean

0
Caulis lonicerae

0
Phellodendri Chinensis Cortex

0
Talc

14807-96-6 26
Forsythiae Fructus

0
Triple Calcium Chewable Tablets
This product is a compound preparation. Each tablet contains 0.05 g of calcium lactate, calcium gluconate, and calcium hydrogen phosphate (equivalent to a total calcium content of 22.6 mg). The excipients are:
Name Description Content CAS NO. Registered Holders
Calcium lactate

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 814-80-2 10
CALCIUM GLUCONATE MONOHYDRATE

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 66905-23-5 33
Calcium phosphate dibasic

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 7757-93-9 14
Chloramphenicol Tablets
The main ingredient of this product is chloramphenicol, and its chemical name is D-threo-(-)-N-[α-(hydroxymethyl)-β-hydroxy-p-nitrophenylethyl]-2,2-dichloroacetamide.
Name Description Content CAS NO. Registered Holders
Chloramphenicol

This product has a broad-spectrum antimicrobial effect in vitro, including aerobic Gram-negative and Gram-positive bacteria, anaerobes, Rickettsia, spirochetes and Chlamydia. It has bactericidal effects on the following bacteria: Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis. It only has antibacterial effects on the following bacteria: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Group B hemolytic Streptococcus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Salmonella typhi, Salmonella paratyphi, Shigella, Bacteroides fragilis and other anaerobic bacteria. The following bacteria are usually resistant to chloramphenicol: Pseudomonas aeruginosa, Acinetobacter, Enterobacter, Serratia marcescens, indole-positive Proteus, methicillin-resistant Staphylococcus and Enterococcus. This product is an antibacterial agent. Chloramphenicol is fat-soluble and its mechanism of action is to diffuse into bacterial cells and reversibly bind to the 50S subunit of bacterial ribosomes, thereby hindering the growth of peptide chains (possibly due to the inhibition of transpeptidase), thereby inhibiting the formation of peptide chains and preventing protein synthesis.

More

This product has a broad-spectrum antimicrobial effect in vitro, including aerobic Gram-negative and Gram-positive bacteria, anaerobes, Rickettsia, spirochetes and Chlamydia. It has bactericidal effects on the following bacteria: Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis. It only has antibacterial effects on the following bacteria: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Group B hemolytic Streptococcus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Salmonella typhi, Salmonella paratyphi, Shigella, Bacteroides fragilis and other anaerobic bacteria. The following bacteria are usually resistant to chloramphenicol: Pseudomonas aeruginosa, Acinetobacter, Enterobacter, Serratia marcescens, indole-positive Proteus, methicillin-resistant Staphylococcus and Enterococcus. This product is an antibacterial agent. Chloramphenicol is fat-soluble and its mechanism of action is to diffuse into bacterial cells and reversibly bind to the 50S subunit of bacterial ribosomes, thereby hindering the growth of peptide chains (possibly due to the inhibition of transpeptidase), thereby inhibiting the formation of peptide chains and preventing protein synthesis.

56-75-7 14
Diclofenac Sodium Enteric-Coated Tablets
The main ingredient of this product is diclofenac. Its chemical name is [o-(2,6-dichloroaniline)]phenylacetic acid.
Name Description Content CAS NO. Registered Holders
1-(2,6-Dichlorophenyl)-2-indolinone

Diclofenac is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid into prostaglandins. At the same time, it can also promote the combination of arachidonic acid with triglycerides (triacylglycerols), reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac is a stronger non-steroidal anti-inflammatory drug, and its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

More

Diclofenac is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid into prostaglandins. At the same time, it can also promote the combination of arachidonic acid with triglycerides (triacylglycerols), reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac is a stronger non-steroidal anti-inflammatory drug, and its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

15307-86-5 4
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.